Oxford begins first human trial of vaccine targeting Bundibugyo Ebola strain

Scientists from the University of Oxford will begin injecting 50 adults in the UK with Ebola 'within weeks' in a bid to build immunity against the deadly virus.

Oxford University scientists have rapidly created and launched a UK trial of Ebola jab using same technology as its AstraZeneca vaccine against Covid-19

First patients have been enrolled in a Ebola treatment trial in the Democratic Republic of Congo as two drugs are being trialed in the Ituri region in a program set up just six…

Recruitment for the vaccination trial has begun, with vaccinations expected to start in the coming weeks • US citizen becomes second to be treated in German hospital • Total DRC…

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.AllNewsSportCultureLifestyleThe University of Oxford is set to begin…

Imunizante é direcionado ao ebolavírus Bundibugyo (BDBV), em resposta ao surto em curso na República Democrática do Congo e no país vizinho, Uganda

Cinquanta volontari sani saranno arruolati nel primo studio clinico di fase 1 del vaccino ChAdOx1 BDBV sviluppato dall'Università di Oxford con il supporto di Cepi. Obiettivo:…

Estudo avaliará segurança e resposta imunológica em 50 adultos saudáveis entre 18 e 55 anos

Oxford begins first human trial of vaccine targeting Bundibugyo Ebola strain

Oxford Vaccine Group initiates the first Phase I trial for Bundibugyo ebolavirus vaccine with support from India's Serum Institute.

Oxford's Ebola vaccine candidate has entered Phase 1 clinical trials for safety evaluation. The ChAdOx1 BDBV vaccine uses a platform similar to the Covid-19 vaccine. Serum…

Scientists in Oxford will start to test the world's first vaccine against Bundibugyo Ebola, as an outbreak of the rare virus strain continues to spread across Congo and Uganda.

Gli scienziati di Oxford inizieranno a testare il primo vaccino al mondo contro l’Ebola Bundibugyo, mentre un focolaio di questo raro ceppo continua a diffondersi tra Congo e…

Leggi su Sky TG24 l'articolo Ebola, primo test sull'uomo del vaccino contro il virus Bundibugyo

The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of…

Scientists have launched the first clinical trial to test whether an experimental antiviral pill can prevent Bundibugyo Ebola after exposure, offering hope for a new…